FDA Reopens Comment Period for Draft Guidance on Social Media and Prescription Drugs

Summary

The FDA is reopening the comment period for its draft guidance on correcting independent third-party misinformation about prescription drugs and medical devices, following a request for additional time and to allow more time for public input.